Top Tech Companies (144)
QIO Technologies is a sustainability tech company delivering Industrial IoT AI software products supporting energy-intensive and asset-heavy Industrial, Data Center and Telecom companies to reduce greenhouse gas emissions, improve energy efficiency, and accelerate operational sustainability. QiO developed its Foresight Sustainability Suite™ in response to the difficulties faced by industry in leveraging large, disparate sources of operational data to reduce GHG...
Exagen Inc. is a Patient Focused, Discovery Driven, CLIA-certified, CAP-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of Rheumatology and Autoimmune diseases. Committed to Personalized Medicine, our AVISE tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. For more information on...
CHAIN Biotechnology was founded in 2014, by serial entrepreneur Dr Edward Green, to exploit the therapeutic potential of Clostridia bacteria found in the human gut microbiome. CHAIN has built an impressive technical team of molecular biology, microbiology, microbiome and fermentation specialists focused on the biotechnology development of Clostridia. In addition, CHAIN leverages synthetic biology expertise from the Synthetic Biology Research...
BenevolentAI combines advanced AI and machine learning with cutting edge science to decipher complex disease biology, generate novel insights and discover more effective medicines. Our unique computational R&D platform spans every step of the drug discovery process, powering an in-house pipeline of 25+ drug programmes from early discovery towards clinical phases. With several successful collaborations with leading pharmaceutical organisations, we...
Founded in 2013, Eleusis is a clinical-stage life science company dedicated to unlocking the full therapeutic potential of psychedelics, guided by science and enabled by drug discovery, clinical development and care delivery design. The company’s comprehensive discovery and development capabilities, together with Andala’s care delivery platform, enable it to target a broad spectrum of unmet needs within psychiatry and beyond...
Let's transform lives together and work towards a functional, confident smile on every face
Apian is transforming healthcare logistics, bringing everyday on-demand delivery to the NHS and beyond. Faster deliveries to more patients with less emissions
Resolution Therapeutics is a biotechnology company developing macrophage cell therapy to treat inflammatory organ disease. The company was founded following a productive collaboration between Edinburgh’s Centre for Regenerative Medicine, the Scottish National Blood Transfusion Service, and Syncona Investment Management Limited. The company is based in the Centre for Regenerative Medicine on the Edinburgh Royal Infirmary Campus, and is backed by...
Pangea develops transformative medicines for neurological disorders, deploying AI to uncover promising molecules from natural sources with prior evidence of efficacy and tolerability in humans based on traditional use
Ascend is an end-to-end gene therapy development partner with deep expertise in gene therapy development and commercialization. We offer unparalleled collaboration while working to develop your products from the bench through the clinic and beyond. Scientific innovation driven by quality and responsibility are at the core of our business. To set a new standard in the industry, we have invested...
Ascend is a development partner that supports life-science innovators in bringing gene therapy products to patients. Our team of experts have more than 120 years of combined experience in gene therapy development and commercialization to offer unparalleled collaboration while working to develop your products from the bench through the clinic and beyond. Scientific innovation driven by quality and responsibility are...
Baseimmune was founded in 2019 as a discovery phase start-up in the antigen discovery and vaccine development field
A science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our three global businesses, scientific and technical know-how and...
The UK's leading provider of insect farms and insect technology • Our mission is to accelerate a global transition to sustainable protein, using insects and technology
Zedsen’s proprietary, non-invasive sensor aims to change the current paradigm of health and oncological care for the better. We are committed to addressing the Institute for Healthcare Improvement’s “Triple Aim'' for optimising healthcare systems, by enhancing the quality of care, improving the health of the overall patient population, and decreasing the cost of healthcare per capita
Valink Therapeutics (formerly LiliumX) is a spinout of the University of Oxford, focused on the development of next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by incorporating bi-/multispecificity, multivalency and drug-conjugation into a single discovery process via our Universal Assembly Platform™. Our internal research focus is on solid tumours poorly addressed by immunotherapy, in addition...
An exciting new cell therapy immunology biotech committed to transforming patient's lives in solid organ transplantation and auto-immune conditions. Our company is growing and we are exciting about the future! Our vision is to become a world leader in new cell therapy and the people are at the heart of what we do. We treat our people with respect, working collaboratively...
GlamorousAI is bringing drugs to every target though its AI-first SaaS platform for drug discovery, RosalindAI. RosalindAI advancing AI to address small, noisy and sparse data challenges with a technology validated experimentally in the lab.
Leucid is progressing novel CAR T therapies that produce a better and more durable response than previous CAR T generations, improving treatment outcomes and saving the lives of patients with refractory cancers.
